APA (7th ed.) Citation

PN, K., DL, R., Y, Y., 3rd, S. A., D, C., S, R., . . . LM, S. (2015). Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. The Journal of experimental medicine, 212(13), 2189. https://doi.org/10.1084/jem.20151074

Chicago Style (17th ed.) Citation

PN, Kelly, et al. "Selective Interleukin-1 Receptor-associated Kinase 4 Inhibitors for the Treatment of Autoimmune Disorders and Lymphoid Malignancy." The Journal of Experimental Medicine 212, no. 13 (2015): 2189. https://doi.org/10.1084/jem.20151074.

MLA (9th ed.) Citation

PN, Kelly, et al. "Selective Interleukin-1 Receptor-associated Kinase 4 Inhibitors for the Treatment of Autoimmune Disorders and Lymphoid Malignancy." The Journal of Experimental Medicine, vol. 212, no. 13, 2015, p. 2189, https://doi.org/10.1084/jem.20151074.